Matthew D. Hill Source Confirmed

Affiliation confirmed via AI analysis of OpenAlex, ORCID, and web sources.

High Impact

CEO

Arkansas State University

faculty

33 h-index 182 pubs 9,200 cited

Research Areas

Cancer Treatment and Pharmacology Neurological disorders and treatments Pharmacological Effects and Toxicity Studies Genomics and Phylogenetic Studies Molecular Biology Techniques and Applications Dementia and Cognitive Impairment Research Cancer-related molecular mechanisms research Neuroscience and Neuropharmacology Research

Links

ORCID Lab Website Research Group

Is this your profile? Verify and claim your profile

OverviewAI-generated summary

Matthew D. Hill's research interests include the development of novel therapeutic agents, particularly focusing on small molecules for cancer treatment and neurological disorders. His work has involved the investigation of BET inhibitors as potential cancer therapeutics, exploring structural diversity and optimizing pharmacokinetic properties. He has also contributed to research on N-methyl-D-aspartate receptor positive allosteric modulators for cognitive impairment.

Beyond drug development, Hill's publications indicate an interest in diverse scientific areas, including the evolutionary relationships of viral protein sequences using computational methods and explorations in oxazoline chemistry. His research group at Arkansas State University engages in various projects, as evidenced by his active lab website and leadership role in research activities. He holds a high-impact researcher designation, reflecting his significant contributions to scientific literature, with an h-index of 33 and over 9,200 citations across 182 publications.

Metrics

  • h-index: 33
  • Publications: 182
  • Citations: 9,200

Selected Publications

  • Liquidity Management and Gender: Evidence from U.S. Households (2025) DOI
  • The Persistent Rise in Corporate Cash Holdings (2025) DOI
  • An Investigation of Trades That Move the BBO Using Strings (2025) DOI

Similar Researchers

Based on overlapping research topics

Mariusz P. Gajewski Arkansas Tech University
Cancer Treatment and Pharmacology Neurological disorders and treatments Pharmacological Effects and Toxicity Studies
Strong match 6 shared topics
Kelsey Hundley University of Arkansas for Medical Sciences
Cancer Treatment and Pharmacology Neurological disorders and treatments Genomics and Phylogenetic Studies
Good match 5 shared topics
Ibón Tamayo University of Arkansas at Fayetteville
Cancer Treatment and Pharmacology Neurological disorders and treatments Genomics and Phylogenetic Studies
Good match 5 shared topics
Henry R. Mahler University of Arkansas for Medical Sciences
Cancer Treatment and Pharmacology Pharmacological Effects and Toxicity Studies Molecular Biology Techniques and Applications
Good match 4 shared topics
Taurean Brown University of Arkansas for Medical Sciences
Cancer Treatment and Pharmacology Pharmacological Effects and Toxicity Studies Molecular Biology Techniques and Applications
Good match 5 shared topics
Erika Horta University of Arkansas for Medical Sciences
Cancer Treatment and Pharmacology Neurological disorders and treatments Pharmacological Effects and Toxicity Studies
Good match 5 shared topics